CEO da Pfizer
Brazil
This entry refers to a news article about Albert Bourla, the CEO of Pfizer, and not to an actual startup. The article reports that Bourla sold 62% of his shares on the same day Pfizer announced positive clinical trial results for its COVID-19 vaccine developed with BioNTech. No startup named 'CEO da Pfizer' exists; the name is a Portuguese phrase meaning 'CEO of Pfizer'.
1 funding rounds tracked. Amounts, dates and investors are available to premium members.
Unlock full funding history
Unlock full funding history
Key people
- Albert Bourla CEO